Tirzepatide for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 5 registered trials.

Why this status

  1. 1 Jan 2025: Trial started, NCT06918405
  2. 9 Apr 2025: Trial registered, NCT06918405
  3. 27 Feb 2026: Trial registered, NCT07438444
  4. 27 Feb 2026: Trial started, NCT07438444
  5. 16 Oct 2026: Trial started, NCT07881458
  6. 19 Oct 2026: Trial registered, NCT07881458

The trials

NCT05536804: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

State
Completed
Phase
Phase 2
People
134 taking part
Started
8 Feb 2023
Primary completion
6 Jul 2026
Arms
Tirzepatide
Results
None posted
  1. 13 Sep 2022: Trial registered
  2. 8 Feb 2023: Trial started
  3. 30 Jul 2026: Trial completed

NCT06918405: Efficacy and Safety of Tirzepatide for Weight Management

State
Under way
Phase
Phase 3
People
440 planned
Started
1 Jan 2025
Primary completion
30 Jun 2026
Arms
Tirzepatide arm
Results
None posted
  1. 1 Jan 2025: Trial started
  2. 9 Apr 2025: Trial registered

NCT07438444: A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

State
Under way
Phase
Phase 4
People
344 planned
Started
27 Feb 2026
Primary completion
Jul 2027
Arms
Tirzepatide
Results
None posted
  1. 27 Feb 2026: Trial registered
  2. 27 Feb 2026: Trial started

NCT07588438: Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

State
Under way
Phase
Phase 4
People
160 planned
Started
27 Jul 2026
Primary completion
10 Aug 2027
Arms
Cohort 1: Obesity Without T2DM, Cohort 2: T2DM With or Without Obesity
Results
None posted
  1. 14 May 2026: Trial registered

NCT07881458: A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

State
Under way
Phase
Phase 3
People
1,000 planned
Started
16 Oct 2026
Primary completion
Oct 2029
Arms
Tirzepatide
Results
None posted
  1. 16 Oct 2026: Trial started
  2. 19 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Arm 5- Tirzepatide, Mounjaro, Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.), Zepbound.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.